Xtant Medical to Issue First Quarter 2023 Financial Results on May 4, 2023

Rhea-AI Summary

Xtant Medical Holdings (NYSE American: XTNT) will announce its Q1 2023 financial results on May 4, 2023, before market open. A conference call will follow at 9:00 AM ET, led by CEO Sean Browne and CFO Scott Neils, to discuss the results. Interested parties can join through dial-in numbers or via a webcast registration link provided in the release. Xtant Medical specializes in medical technology, focusing on orthobiologics and spinal implant systems for spinal fusion procedures. The company emphasizes integrity and dedication in serving its customers. For further information, a replay of the call will be accessible on the company's website after the live event.

BELGRADE, Mont., April 27, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2023, before the open of the financial markets on Thursday, May 4, 2023.

Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, May 4 at 9:00 AM ET to review results.

Conference Details
Conference Call Date: Thursday, May 4, 2023 - 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q1 2023 Financial Results
Webcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com

FAQ

When will Xtant Medical release its Q1 2023 financial results?

Xtant Medical will release its Q1 2023 financial results on May 4, 2023, before the market opens.

What time is the conference call for Xtant Medical's Q1 2023 results?

The conference call is scheduled for May 4, 2023, at 9:00 AM ET.

How can I join the conference call for Xtant Medical's financial results?

You can join the conference call by dialing 877-407-6184 for domestic calls or 201-389-0877 for international calls.

Where can I find the replay of the Q1 2023 financial results call for Xtant Medical?

The replay will be available on Xtant Medical's website under the 'Investor Info' section.

What is the focus of Xtant Medical's business?

Xtant Medical focuses on the design, development, and commercialization of orthobiologics and spinal implant systems for spinal fusion procedures.